Give now!
  • church3
    The Center for Vaccines and Immunology provides an exciting and friendly
    work environment for all its research faculty, staff, and students.
  • church3
    Dr. Jarrod Mousa is an Assistant Professor in the CVI.
    His research focuses on the structural and molecular basis for human antibody mediated immunity to infectious pathogens.
  • church3
    The CVI supports graduate and undergraduate students from many programs and offers
    multiple opportunities to participate in research, earn class credit, attend seminars, activities, and events.
  • church3
  • church3
    Discovery in the CVI: The Center for Vaccines and Immunology serves as a training ground for tomorrow's scientists,
    while also helping UGA forge new ground in translational research.
  • church3
    Dr. Mark Tompkins is a Professor in Infectious Diseases who studies emerging and
    seasonal influenza virus infections to design vaccines and therapeutics.
  • church3
    Dr. Karen Norris is the Georgia Research Alliance Eminent Scholar in Immunology and Translational Biomedicine.
    Her research focuses on infectious and chronic diseases, including HIV, pulmonary diseases, inflammatory diseases and diabetes.

Welcome To The Center for Vaccines and Immunology


The CVI hosts a variety of seminars throughout the year. Check back often to find upcoming seminars that may be of interest to you.

Jessica Lancaster, Ph.D.
University of Texas at Austin
Molecular Biosciences

Date: Jul 11 (Thursday), 2019
Location: S175 Coverdell Building
Topic: Two-photon imaging reveals thymocyte migration and dynamic cellular interactions to establish T cell central tolerance

Chester Joyner, Ph.D.
Emory University School of Medicine
Yerkes National Primate Research Center

Date: Jul 18 (Thursday), 2019
Location: S175 Coverdell Building
Topic: Immunology and Pathogenesis of Relapsing Plasmodium infections

See All Seminars

Director's Comments

Dr. Ted Ross The development of vaccines is one of the greatest achievements of biomedical sciences and public health. New vaccines, together with inoculation programs, led to a dramatic decline in human cases of measles, mumps, rubella, polio, tuberculosis and the eradication of smallpox during the 20th century. More recently, the use of new technologies has resulted in the licensure of vaccines for human papillomaviruses, dengue and chicken pox. Vaccines and vaccination also have been highly effective for the veterinary field, resulting in enhanced lives of pet animals and improvement in the quality of raising animals for food production, which lowers costs to the consumer. Remarkably, vaccines are also being used in areas of human health not related to infectious diseases, such as Alzheimer’s disease and cancer.

The partnership of CVI-based faculty with CVI-associated researchers from across the UGA campus yields a deep bench of experts who engage in vaccine-focused research in collaboration with individuals from business, academia and government agencies to create an atmosphere in which students, research scientists and faculty contribute to the development and assessment of new and existing vaccines.

The University of Georgia is uniquely qualified to accommodate a Center for Vaccines and Immunology because it has diverse, world-renowned expertise within the areas of infectious disease, veterinary medicine, ecology and public health. By engaging UGA’s world-class biocontainment research resources and the expertise of scientists from surrounding institutions, CVI investigators can focus on translational studies to test and assess the efficacy of vaccines and immunotherapies in development by industry, governmental and academic institutions.

With its base at the UGA College of Veterinary Medicine, the CVI is uniquely positioned for translational vaccinology amid an established ecosystem of active research partners, including the Emory Vaccine Center, the U.S. Centers for Disease Control and Prevention, the U.S. Department of Agriculture’s Southeast Poultry Research Laboratories, as well as global and local companies, such as Sanofi-Pasteur and Merial Limited. This collaborative network, combined with the support provided to the CVI from the Georgia Research Alliance, facilitates the CVI’s investigators in their quest to explore, invest in and expand the active vaccine translational community for assessment of vaccines. Our partnership with both local and international organizations also strengthens our outreach to established researchers in Puerto Rico, Africa and Southeast Asia, and further enhances the CVI’s ability to be a unique home for translational vaccinology and understanding the science behind vaccines.

If you are interested in joining our team, collaborating with our faculty or utilizing our core facilities for assessment of vaccines, adjuvants, or immunotherapies in well-established animal models and clinical trial units, please contact me through one of the phone numbers or the email address listed below.